Ozempic Could Reduce Heart Attack Risk
- Cardio
- 22/05/2024
A recent analysis shows that semaglutide, a prescription drug (brand names Wegovy and Ozempic), may reduce the risk of heart attacks and stro
READ MOREA recent analysis shows that semaglutide, a prescription drug (brand names Wegovy and Ozempic), may reduce the risk of heart attacks and stro
READ MOREObesity prevalence has steadily risen, affecting over 40% of U.S. adults aged 20 and older. Scientific advances have illuminated the multiface
READ MOREDespite advances in reducing mortality and hospitalisation rates, individuals living with hypertrophic cardiomyopathy (HCM) often ex
READ MOREPhilips ePatch and AI Analytics Rolled Out to 14 Spanish Hospitals for Heart Patient Monitoring
READ MOREMODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
READ MORENon-Invasive Technologies for Continuous Hemodynamic Monitoring in Clinical Use are on the Rise
READ MOREMedtronic's Affera™ System Shows Promising Safety and Efficacy in Atrial Fibrillation Treatment
READ MOREPhilips shows AI-powered cardiac monitoring benefits at Heart Rhythm Annual Meeting
READ MOREAndreas Grüntzig Ethica Award winners of EuroPCR 2024: Ottavio Alfieri and Frederick St Goar
READ MOREGE HealthCare and Medis Medical Imaging Collaborate on Non-Invasive Coronary Assessments
READ MORE